Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevent-SVD: Cilostazol and Isosorbide Mononitrate in Small Vessel Disease
NCT02481323Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Mar 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cilostazol, isosorbide mononitrate in Cerebral Small Vessel Disease (CSVD), sponsored by University of Edinburgh. Started Mar 2016; status: completed.
02
Drugs
cilostazolisosorbide mononitrate
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT02481323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02481323.